Literature DB >> 2452527

MHC-antigens: constituents of the envelopes of human and simian immunodeficiency viruses.

H Gelderblom1, H Reupke, T Winkel, R Kunze, G Pauli.   

Abstract

Immunoelectron microscopy was applied to study the antigenic make-up of human and simian immunodeficiency viruses (HIV, SIV) grown in cells expressing either MHC class I (Molt-3) or MHC class I and II (H9) antigens. A variety of antibodies directed against the surface glycoprotein gp120 of HIV and against MHC class I and II antigens were employed. Consistent with earlier observations on the loss of HIV envelope components, gp120 was only weakly demonstrable on the mature virion. MHC class I determinants were present regularly in small amounts on HIV and SIV. Class II antigens, e.g. HLA-DR were found in high density on HIV and SIV grown in H9 cells, but were absent, as expected, on virus grown in Molt-3 cells. These cellular surface antigens are constituents of the virion. The presence of MHC class II antigens in virus preparations used for diagnostic purposes might explain some of the false positive results in HIV serology. Possible biological implications of these virus associated cellular antigens for the pathogenicity of HIV are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2452527     DOI: 10.1515/znc-1987-11-1230

Source DB:  PubMed          Journal:  Z Naturforsch C J Biosci        ISSN: 0341-0382


  18 in total

1.  Expression of nef, vpu, CA and CD4 during the infection of lymphoid and monocytic cell lines with HIV-1.

Authors:  T Schneider; P Hildebrandt; K Rokos; U Schubert; W Rönspeck; C Grund; A Beck; R Blesken; G Kulins; H Oldenburg
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Host cell antigenic profile acquired by HIV-1 is a marker of its cellular origin.

Authors:  I Abbate; M R Capobianchi; S Fais; C Castilletti; F Mercuri; P Cordiali Fei; F Ameglio; F Dianzani
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

Review 3.  Virus maturation by budding.

Authors:  H Garoff; R Hewson; D J Opstelten
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

4.  Epithelial uptake and transport of cell-free human immunodeficiency virus type 1 and gp120-coated microparticles.

Authors:  A Kage; E Shoolian; K Rokos; M Ozel; R Nuck; W Reutter; E Köttgen; G Pauli
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Contribution of virion ICAM-1 to human immunodeficiency virus infectivity and sensitivity to neutralization.

Authors:  C D Rizzuto; J G Sodroski
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

6.  Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity.

Authors:  J F Fortin; R Cantin; G Lamontagne; M Tremblay
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

Review 7.  Dengue fever virus and Japanese encephalitis virus synthetic peptides, with motifs to fit HLA class I haplotypes prevalent in human populations in endemic regions, can be used for application to skin Langerhans cells to prime antiviral CD8+ cytotoxic T cells (CTLs)--a novel approach to the protection of humans.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1994-09       Impact factor: 2.332

8.  Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus.

Authors:  L O Arthur; J W Bess; R G Urban; J L Strominger; W R Morton; D L Mann; L E Henderson; R E Benveniste
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

Review 9.  Morphogenesis and morphology of HIV. Structure-function relations.

Authors:  H R Gelderblom; M Ozel; G Pauli
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

Review 10.  HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1994-07       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.